Welcome to LookChem.com Sign In|Join Free
  • or
1,4-Diazaspiro[5.5]undecane-5,9-dione HCl is a heterocyclic compound that features a diazaspiro ring system. As the hydrochloride salt form of the compound, it is frequently utilized as a research chemical and within the pharmaceutical industry. 1,4-Diazaspiro[5.5]undecane-5,9-dione HCl possesses potential biological activity and has been investigated for its possible role in addressing a range of medical conditions, particularly neurological and psychiatric disorders. Its distinctive structure and properties have garnered attention in the realms of chemistry and pharmacology, with ongoing exploration into its specific applications and functions. 1,4-Diazaspiro[5.5]undecane-5,9-dione HCl holds promise as a prospective therapeutic agent.

1263475-13-3

Post Buying Request

1263475-13-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1263475-13-3 Usage

Uses

Used in Pharmaceutical Applications:
1,4-Diazaspiro[5.5]undecane-5,9-dione HCl is used as a research chemical for the development and study of new pharmaceuticals. Its unique structure and potential biological activity make it a valuable compound for exploring its efficacy in treating various medical conditions.
Used in Chemical Research:
In the field of chemical research, 1,4-Diazaspiro[5.5]undecane-5,9-dione HCl is used as a subject of interest for understanding its properties and behavior. This knowledge can contribute to the advancement of chemistry and the discovery of new applications for the compound.
Used in Neurological and Psychiatric Disorders Treatment:
1,4-Diazaspiro[5.5]undecane-5,9-dione HCl is being studied for its potential role in the treatment of neurological and psychiatric disorders. Its biological activity and unique structure suggest that it may offer therapeutic benefits in these areas, although further research is necessary to confirm its effectiveness and safety.

Check Digit Verification of cas no

The CAS Registry Mumber 1263475-13-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,6,3,4,7 and 5 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1263475-13:
(9*1)+(8*2)+(7*6)+(6*3)+(5*4)+(4*7)+(3*5)+(2*1)+(1*3)=153
153 % 10 = 3
So 1263475-13-3 is a valid CAS Registry Number.

1263475-13-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 1,4-diazaspiro[5.5]undecane-5,9-dione,hydrochloride

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1263475-13-3 SDS

1263475-13-3Relevant academic research and scientific papers

FUMARIC ACID SALT OF 9-[4-(3-CHLORO-2-FLUORO-PHENYLAMINO)-7-METHOXY- CHINAZOLIN-6-YLOXY]-1,4-DIAZA-SPIRO[5.5]UNDECAN-5-ONE, ITS USE AS MEDICAMENT AND THE PREPARATION THEREOF

-

, (2014/02/15)

The present invention relates to a compound of formula (I), which has valuable pharmacological properties, particularly an inhibiting effect on signal transduction mediated by tyrosine kinases, processes for stereoselectively preparing these compounds, particularly pharmaceutical formulations suitable for inhalation and their use for the treatment of diseases, particularly tumoral diseases, benign prostatic hyperplasia and diseases of the lungs and airways.

FUMARIC ACID SALT OF 9-[4-(3-CHLORO-2-FLUORO-PHENYLAMINO)-7-METHOXY-QUINAZOLIN-6-YLOXY]-1,4-DIAZA-SPIRO[5.5]UNDECAN-5-ONE, ITS USE AS A MEDICAMENT AND THE PREPARATION THEREOF

-

, (2014/02/16)

The present invention relates to a compound of formula (I), which has valuable pharmacological properties, particularly an inhibiting effect on signal transduction mediated by tyrosine kinases, processes for stereoselectively preparing these compounds, particularly pharmaceutical formulations suitable for inhalation and their use for the treatment of diseases, particularly tumoral diseases, benign prostatic hyperplasia and diseases of the lungs and airways.

9-[4-(3-CHLORO-2-FLUORO-PHENYLAMINO)-7-METHOXY-QUINAZOLINE-6-YLOXY]-1,4-DIAZA-SPIRO[5.5]UNDECANE-5-ONE DIMALEATE, USE THEREOF AS A MEDICAMENT AND METHOD FOR THE PRODUCTION THEREOF

-

, (2013/03/26)

The present invention relates to a compound of formula (I), which has valuable pharmacological properties, particularly an inhibiting effect on signal transduction mediated by tyrosine kinases, processes for stereoselectively preparing these compounds, particularly pharmaceutical formulations suitable for inhalation and their use for the treatment of diseases, particularly tumoral diseases, benign prostatic hyperplasia and diseases of the lungs and airways.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1263475-13-3